National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2019

Laurie D. Elam–Evans(Center for Surveillance, Epidemiology, and Laboratory Services), David Yankey(Center for Surveillance, Epidemiology, and Laboratory Services), James A. Singleton(Center for Surveillance, Epidemiology, and Laboratory Services), Natalie Sterrett(Center for Surveillance, Epidemiology, and Laboratory Services), Lauri E. Markowitz(Center for Surveillance, Epidemiology, and Laboratory Services), Charnetta Williams(Center for Surveillance, Epidemiology, and Laboratory Services), Benjamin Fredua(Center for Surveillance, Epidemiology, and Laboratory Services), Lucy A. McNamara(Center for Surveillance, Epidemiology, and Laboratory Services), Shannon Stokley(Center for Surveillance, Epidemiology, and Laboratory Services)
MMWR Morbidity and Mortality Weekly Report
August 20, 2020
10.15585/mmwr.mm6933a1
Cited by 367Open Access
Full Text

Abstract

had lower coverage with ≥1 dose of MenACWY and with ≥1 HPV vaccine dose, and a lower percentage were HPV UTD, compared with those living in MSA principal cities. In early 2020, the coronavirus disease 2019 (COVID-19) pandemic changed the way health care providers operate and provide routine and essential services. An examination of Vaccines for Children (VFC) provider ordering data showed that vaccine orders for HPV vaccine; tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccine (Tdap); and MenACWY decreased in mid-March when COVID-19 was declared a national emergency (Supplementary Figure 1, https://stacks.cdc.gov/view/cdc/91795). Ensuring that routine immunization services for adolescents are maintained or reinitiated is essential to continuing progress in protecting persons and communities from vaccine-preventable diseases and outbreaks.

Related Papers

No related papers found

Powered by citation graph analysis